What this means
This commentary highlights earlier vaccine studies in an older-adult journal. It does not test anything new, and it points out that some links to dementia are not proven.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A summary of earlier studies, including studies of care-home residents
- Kind of research
- A summary of earlier studies
The science
- Original title
- Recent research on vaccines for older adults.
- Authors
- Soiza RL, Veronese N
- Journal
- Age and ageing
- Published
- Oct 26, 2026
- Study type
- Review · in humans
- PMID
- 42933996 ↗
Abstract
Vaccination is increasingly recognised as a cornerstone of healthy ageing and geriatric care, extending beyond the prevention of infectious disease to potentially influence broader health outcomes. This Commentary article commemorates the launch of Age and Ageing's vaccines collection by highlighting key vaccine-related research published in the journal. It focuses on vaccine uptake, effectiveness and emerging research priorities for older adults. Uptake of recommended vaccines, including influenza, COVID-19, respiratory syncytial virus and pneumococcal vaccines, remains variable internationally and is challenged by vaccine hesitancy. Successful vaccination programmes combine healthcare professional education, centralised reminder systems and easy access to vaccination services. Studies involving care-home residents demonstrated that COVID-19 vaccines provided substantial protection against infection and, particularly, mortality, although effectiveness declines over time and is influenced by immunosenescence. Immunological studies reveal weaker vaccine responses among infection-naïve older adults, supporting the importance of booster programmes and strategies to enhance immunity. Emerging evidence also suggests that interventions such as probiotics may improve vaccine immunogenicity, although further high-quality trials are required. Beyond infection prevention, observational data indicate that several vaccines, may be associated with a reduced risk of dementia, particularly vascular dementia, though causal relationships remain unproven. Looking forward, greater inclusion of frail older adults and care home residents in vaccine trials is essential to strengthen the evidence base. Future research should support the development of novel vaccines, improve preparedness for future pandemics and optimise vaccination strategies to maximise healthy ageing and preserve function in later life.
Soiza RL, Veronese N Recent research on vaccines for older adults. Age and ageing. 2026. doi:10.1093/ageing/afag313. PMID: 42933996. https://pubmed.ncbi.nlm.nih.gov/42933996/
See all research on Vaccines for adults →